AGM/EGMApr 27, 2026, 04:34 PM
SER Annual Meeting: Authorized Shares to 125M, Equity Plan +2M
AI Summary
Serina Therapeutics, Inc. (SER) announced its Annual Meeting of Stockholders to be held virtually on June 17, 2026. Key proposals include the election of three Class III directors, a significant increase in authorized common stock from 40 million to 125 million shares, and an increase of 2 million shares for the 2024 Equity Incentive Plan. Stockholders will also vote on the issuance of common stock related to Series A Preferred Stock conversion and Private Placement Securities exercise, advisory votes on executive compensation, and the ratification of auditors.
Key Highlights
- SER to hold Annual Meeting on June 17, 2026, as a virtual meeting.
- Stockholders to elect three Class III directors: Gregory H. Bailey, Richard Marshall, and Jay Venkatesan.
- Proposal to increase authorized common stock from 40M to 125M shares.
- Proposal to increase shares for 2024 Equity Incentive Plan by 2M shares.
- Proposal to approve common stock issuance for Series A Preferred Stock conversion.
- Proposal to approve common stock issuance for Private Placement Securities exercise.
- Advisory vote on Named Executive Officer compensation (Say-on-Pay Proposal).
- Advisory vote on frequency of future Say-on-Pay votes (Board recommends every three years).
- Ratification of Frazier & Deeter, LLC as independent registered public accountants for 2026.
Price Impact
More from SER